Scholay

学术搜索 · AI 审稿 · LaTeX 协作

Christophe Guignabert

机构:Inserm, Université Paris-Saclay, Assistance Publique – Hôpitaux de Paris, Hypertension pulmonaire : physiopathologie et innovation thérapeutique, Bicêtre Hospital · ORCID:0000-0002-8545-4452

发表论文 320 篇 · 总被引 15624 次 · h-index 65

代表论文

  • Drugs targeting novel pathways in pulmonary arterial hypertension (2025 · European Respiratory Journal · 被引 25)
  • Severe Hypoxemia and Pulmonary Capillary Dilatations in Pulmonary Arterial Hypertension Patients Treated with Sotatercept (2025 · American Journal of Respiratory and Critical Care Medicine · 被引 16)
  • Bone morphogenetic protein-9 controls pulmonary vascular growth and remodeling (2025 · Proceedings of the National Academy of Sciences · 被引 10)
  • IDO‐1 Promotes Pulmonary Vascular Remodeling Via Kynurenine Pathway in Pulmonary Arterial Hypertension (2025 · Journal of the American Heart Association · 被引 9)
  • BMP9 Modulates IL-33 Signaling to Mitigate EndMT in Pulmonary Arterial Hypertension (2026 · Hypertension · 被引 4)
  • The activin pathway in chronic thromboembolic pulmonary hypertension: a potential biomarker for residual pulmonary hypertension after endarterectomy (2025 · ERJ Open Research · 被引 2)